aMolecular Neuropsychiatry & Development (MiND) Lab, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health

bInstitute of Medical Science, University of Toronto, Toronto, ON

cDepartment of Biochemistry and Microbiology, University of Victoria, Victoria, BC

dDepartment of Psychiatry, University of Toronto, Toronto, ON, Canada

Received 8 March 2023 Accepted 9 August 2023.

Supplemental Digital Content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's website, www.psychgenetics.com.

Correspondence to John B. Vincent, PhD, Senior Scientist and Head of Molecular Neuropsychiatry and Development (MiND) Lab, Molecular Brain Science, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, 250 College Street, Toronto, ON, M5T 1R8, Canada, Tel: +416 535 8501; e-mail: [email protected]